Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Completed · Phase 4

Conditions studied: Glaucoma

In brief

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Key facts

Study ID

NCT00347802

Run by

Innovative Medical

Last updated by the study team

2007-06-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• · Male or female > 18 years of age
• Naive to treatment or washed off any ocular hypotensive agents
• Untreated IOP >19 mm Hg
• Diagnosis of open-angle glaucoma or ocular hypertension
• Ability to provide informed consent and likely to complete study

You may not qualify if…

• · Known contraindication to bimatoprost or travoprost, or any component of any study medication
• Uncontrolled systemic disease
• Active ocular disease other than glaucoma or ocular hypertension
• Required use of ocular medications other than the study medications during the study
• History of intraocular surgery within the last 3 months
• Prior discontinuation of any of the study medications for reasons related to efficacy or safety

Where it is running

• Dr. Noecker — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.